Can Antibiotics Cause Pancreatitis?

Antibiotics can cause acute pancreatitis, though the risk is low. Drug-induced pancreatitis accounts for up to about 5% of all acute pancreatitis cases, and antibiotics represent a meaningful slice of the drugs implicated.¹ The connection is well-documented enough that clinicians have classification systems ranking individual drugs by how strong the evidence is, yet rare enough that many doctors don’t think of it right away when a patient on antibiotics develops abdominal pain.

How Strong Is the Evidence for Specific Antibiotics

Not all antibiotics carry equal suspicion. A widely used classification system groups drugs into four tiers based on how convincing the published case reports are. The strongest tier (Class I) includes drugs where pancreatitis recurred after the patient was deliberately or accidentally re-exposed to the same medication. The next tier (Class II) covers drugs where the timing between starting the medication and developing pancreatitis is consistent across most reported cases. Lower tiers capture drugs with only scattered reports and no clear pattern.² A narrative review of antimicrobial agents found 51 suspected associations between antibiotics or antivirals and acute pancreatitis, with metronidazole ranking among the drugs with the most supporting evidence.¹

The distinction between these tiers matters because a drug in the top tier carries real clinical weight: if a patient’s pancreatitis goes away when the drug is stopped and comes back when the drug is restarted, that’s about as convincing as case-level evidence gets. A drug with only one published case report, by contrast, could easily be coincidence.

Metronidazole

Metronidazole is one of the best-documented antibiotic culprits. It’s commonly prescribed for dental infections, bacterial vaginosis, and certain gut infections, so a lot of people encounter it. In one well-described case, a patient developed pancreatitis after just three doses of metronidazole for a dental abscess and had experienced a similar episode ten months earlier on the same drug. No alcohol use, no gallstones, no other medications were involved either time, and symptoms resolved quickly once the antibiotic was stopped.³ Across the literature, at least five patients have had pancreatitis recur after being re-exposed to metronidazole, which is the gold standard for establishing a drug as a cause.⁴

A related drug, ornidazole (which belongs to the same nitroimidazole family), has also been linked to pancreatitis. In one case involving a combination tablet of ofloxacin and ornidazole prescribed for diarrhea, the patient developed pancreatitis, recovered after the drug was stopped, and then had pancreatitis again three years later when the same combination was prescribed by a different doctor.⁵ These repeat episodes are what push a drug up the evidence ladder from “suspicious” to “likely causal.”

Tetracyclines

Tetracyclines are one of the few antibiotic classes studied with something more rigorous than case reports. A Swedish population-based study compared people with acute pancreatitis against matched controls and found that current tetracycline users had roughly 60% higher odds of developing acute pancreatitis after adjusting for other risk factors. Importantly, people who had used tetracyclines in the past but were no longer taking them showed no increased risk, which suggests the effect is tied to active use rather than permanent damage.⁶

That finding is notable because most antibiotic-pancreatitis evidence comes from individual case reports, which can’t quantify risk. A population-level study showing a clear and statistically meaningful signal makes the connection harder to dismiss as coincidence. Still, a 60% increase in a rare event means the absolute risk remains small for any individual patient.

Newer tetracycline-class drugs used in hospital settings also appear on the radar. Tigecycline, a broad-spectrum intravenous antibiotic, generated enough adverse event reports in the FDA’s safety database to produce a statistical signal linking it to pancreatitis, though the nature of that database means a definitive cause-and-effect relationship can’t be confirmed from reporting data alone.⁷ A newer relative, eravacycline, showed an even stronger signal in a pharmacovigilance analysis, with pancreatitis flagged as a safety concern not prominently described in its prescribing information.⁸

Fluoroquinolones

Fluoroquinolones like ciprofloxacin, levofloxacin, and ofloxacin are among the most widely prescribed antibiotics in the world, used for urinary tract infections, respiratory infections, and gut infections. Pancreatitis linked to this class is rare but documented. In a study of 227 patients receiving ciprofloxacin for infectious colitis, seven (about 3%) developed pancreatitis during treatment, typically around five to six days after starting the drug. The pancreatitis resolved completely in all cases after the ciprofloxacin was stopped, with recovery taking an average of about eleven days.⁹

Levofloxacin has been reported in similar fashion. In one case, a 74-year-old man treated for a bladder infection developed severe abdominal pain, nausea, and fever two days after starting levofloxacin. His pancreatic enzyme levels were sharply elevated, imaging showed swelling in the pancreas, and no other cause could be found. He recovered fully once the drug was withdrawn.¹⁰

Trimethoprim-Sulfamethoxazole

Trimethoprim-sulfamethoxazole (often called TMP-SMX or by brand names like Bactrim) is widely used for urinary tract infections, skin infections, and as a preventive antibiotic in people with weakened immune systems. A clear recurrence case involved a 32-year-old man who developed pancreatitis while taking TMP-SMX for a urinary infection. When his medical history was reviewed carefully, it turned out he had also been on TMP-SMX during a previous unexplained episode of pancreatitis two years earlier, making the drug the most likely cause.¹¹

People with HIV/AIDS deserve special mention here because TMP-SMX is frequently given to them as prophylaxis against opportunistic infections, sometimes for months or years. A case report described a woman with AIDS who developed pancreatitis alongside other adverse reactions while receiving the drug.¹² People with HIV are already at higher baseline risk for pancreatitis due to other medications they take and the effects of the virus itself, so TMP-SMX’s contribution can be hard to isolate but is clinically relevant. In a pediatric study, TMP-SMX was among the drugs most commonly associated with pancreatitis in children, after steroids, valproic acid, and mesalamine.¹³

Less Common Culprits

Erythromycin, a macrolide antibiotic commonly prescribed for respiratory infections and sometimes used to promote gut motility, has been linked to pancreatitis in a handful of published cases.¹⁴ The evidence base is thin, but it exists. Linezolid, a hospital-grade antibiotic reserved for serious drug-resistant infections like MRSA, has also been linked to pancreatitis in rare cases. The suspected mechanism involves damage to mitochondria, which could compromise blood flow to pancreatic tissue and injure the cells that produce digestive enzymes.¹⁵

These are drugs you’re less likely to encounter in everyday outpatient care, but they’re worth knowing about if you or a family member is hospitalized and receiving intravenous antibiotics for a serious infection.

Why It’s Hard to Diagnose

Pinning pancreatitis on an antibiotic is a process of elimination. Gallstones and heavy alcohol use cause the vast majority of pancreatitis cases, and those have to be ruled out first. The diagnostic workup typically involves checking blood levels of lipase and amylase (enzymes the pancreas produces), along with triglyceride and calcium levels, liver function tests, and imaging such as an abdominal ultrasound to look for gallstones or tumors that could be blocking the pancreatic duct.¹⁶

Only after the common causes are excluded does the conversation turn to medications. This is why so many cases of drug-induced pancreatitis are probably missed or mislabeled. If you had a few beers last week and develop pancreatitis while on antibiotics, alcohol is likely to get the blame even if the antibiotic was the real trigger. The clinician would need to take a careful medication history and consider the timeline: did symptoms start days after beginning a new drug? Did a similar episode happen during a previous course of the same drug?

One complicating factor is that some medications cause temporary bumps in pancreatic enzyme levels without causing actual pancreatitis. A systematic review found that routine monitoring of pancreatic enzymes through blood tests or serial ultrasounds was not useful for catching drug-induced pancreatitis early in most patients. Only in people already known to be at high risk did serial enzyme monitoring offer any benefit in guiding early drug discontinuation.¹⁷ In other words, elevated enzymes on a blood test don’t automatically mean the pancreas is inflamed, and chasing those numbers with imaging in every patient on a suspect drug isn’t practical.

How Drug-Induced Pancreatitis Compares in Severity

If there’s a silver lining, it’s that antibiotic-induced pancreatitis tends to be less severe than the pancreatitis caused by gallstones or alcohol. A large analysis of U.S. hospital records from 2016 through 2021 found that drug-induced pancreatitis was associated with lower odds of serious complications like bleeding and the need for drainage procedures compared to gallstone-related pancreatitis. Hospital stays were shorter and total costs were lower as well. Mortality was not significantly different from the baseline for drug-induced cases, whereas alcohol-related pancreatitis carried higher odds of death.¹⁸

The reason is straightforward: once the offending drug is stopped, the trigger is removed. Gallstones don’t go away on their own, and alcohol-induced pancreatitis often reflects years of cumulative damage. With a drug reaction, the pancreas typically recovers once the chemical insult is gone. In the ciprofloxacin study mentioned earlier, all seven patients with pancreatitis recovered completely after the drug was stopped.⁹

What to Do If You Suspect a Problem

The practical advice here is simple but important. If you develop upper abdominal pain that radiates to your back, nausea, or vomiting while taking an antibiotic, get medical attention. Don’t stop the antibiotic on your own without talking to a doctor, because the infection it’s treating could be serious, but do mention the timeline: when you started the drug and when symptoms appeared. That timing is often the single most useful clue.

If you have a documented history of pancreatitis that was possibly linked to a specific antibiotic, make sure every prescriber you see knows about it. The rechallenge cases in the literature are cautionary tales. Several patients developed pancreatitis a second time simply because no one connected the dots between their past episode and the same medication being prescribed again by a different doctor. The severity can increase with repeated exposures, so avoiding the implicated drug is important.

For people who take antibiotics frequently, such as those with chronic lung conditions, recurrent urinary infections, or compromised immune systems, discussing alternatives with your prescriber is worthwhile if you’ve had any unexplained episodes of abdominal pain during previous antibiotic courses.

Children and Drug-Induced Pancreatitis

Drug-induced pancreatitis is not just an adult problem. A study of 271 pediatric pancreatitis cases found that drugs were associated with the condition in about a quarter of them. The most commonly implicated medications in children were corticosteroids, valproic acid (an anti-seizure drug), and mesalamine (used for inflammatory bowel disease), with TMP-SMX also on the list.¹³ Antibiotics as a group are a less prominent cause in children than some other drug classes, but TMP-SMX’s appearance is worth noting because it’s one of the most commonly prescribed antibiotics in pediatric care.

Pancreatitis in children can be easy to overlook because abdominal pain is such a common and vague complaint at young ages. If a child on antibiotics develops persistent upper belly pain, especially with vomiting and poor appetite, it’s reasonable for a parent to raise the possibility with the pediatrician.

The Gut Microbiome Angle

Beyond directly triggering pancreatitis through toxic effects on the pancreas, antibiotics reshape the bacterial community in the gut, and there is growing interest in whether that disruption itself contributes to pancreatic inflammation. In the setting of acute pancreatitis from any cause, poor blood flow to the gut lining can break down the barrier between intestinal bacteria and the rest of the body. One meta-analysis found that about 59% of patients with acute pancreatitis have measurable gut barrier dysfunction, and circulating bacterial DNA from gut microbes has been detected in roughly two-thirds of acute pancreatitis patients in one study.¹⁹

Whether antibiotic-driven changes in gut bacteria can independently push someone toward pancreatitis remains speculative. But the connection between gut health and pancreatic inflammation is being actively studied, and it adds another layer of plausibility to the idea that antibiotics can affect the pancreas through more than one pathway. This research is still early enough that no clinical recommendations have come from it, but it may eventually change how clinicians think about antibiotic stewardship in patients already at risk for pancreatic disease.

1
PubMed Central. Drug-Induced Acute Pancreatitis in Adults: Focus on Antimicrobial and Antiviral Drugs, a Narrative Review
2
PubMed. Drug-induced acute pancreatitis: an evidence-based review
3
PubMed Central. Metronidazole-induced pancreatitis
4
International Journal of Case Reports and Images. Metronidazole induced acute pancreatitis
5
PubMed Central. Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge
6
Gut. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case–control study
7
PubMed. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports
8
PubMed. Real-world safety profile of eravacycline compared with tigecycline, minocycline, and meropenem: a comparative pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)
9
Gut and Liver. Acute Pancreatitis Secondary to Ciprofloxacin Therapy in Patients with Infectious Colitis
10
PubMed Central. Levofloxacin-Induced Acute Pancreatitis
11
PubMed Central. A case of recurrent pancreatitis induced by trimethoprim-sulfamethoxazole re-exposure
12
PubMed. Adverse reactions to trimethoprim/sulfamethoxazole in AIDS
13
PubMed Central. Novel Characterization of Drug-associated Pancreatitis in Children
14
PubMed. Erythromycin-induced acute pancreatitis
15
American Journal of Case Reports. Linezolid-Associated Triad of Acute Pancreatitis, Lactic Acidosis, and Hypoglycemia: A Rare Case Report and Literature Review
16
Ochsner Journal. Drug-Induced Acute Pancreatitis: A Review
17
BMJ Open. Methods for the early detection of drug-induced pancreatitis: a systematic review of the literature
18
PubMed Central. Comparative outcomes and characteristics of biliary, alcoholic and drug-induced pancreatitis based on the National Inpatient Sample (2016-2021)
19
PubMed Central. The Gut Microbiome in Pancreatic Disease